SIMILAR PATTERNS OF AMINO ACIDS FOR 3POC_B_ACRB664_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nnh | ASPARAGINYL-TRNASYNTHETASE-RELATEDPEPTIDE (Pyrococcusfuriosus) |
PF00152(tRNA-synt_2) | 5 | ASP A 173ILE A 208ILE A 186ARG A 191ASP A 52 | None | 1.23A | 3pocB-1nnhA:undetectable | 3pocB-1nnhA:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 212ILE A 213ILE A 249TRP A 284MET A 321ARG A 400TRP A 413ASP A 416PHE A 449HIS A 480 | NoneNoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A)NoneBOG A2000 (-3.0A)NoneNone | 0.55A | 3pocB-2g3nA:42.5 | 3pocB-2g3nA:27.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 212ILE A 213ILE A 249TRP A 284TRP A 318TRP A 413PHE A 449HIS A 480 | None | 1.02A | 3pocB-2g3nA:42.5 | 3pocB-2g3nA:27.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 212ILE A 249MET A 321ARG A 400ASP A 416PHE A 449HIS A 480 | NoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A)BOG A2000 (-3.0A)NoneNone | 1.40A | 3pocB-2g3nA:42.5 | 3pocB-2g3nA:27.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 7 | ASP A 412MET A 554ARG A 649TRP A 662ASP A 665PHE A 698HIS A 731 | QPS A1050 (-3.2A)QPS A1050 (-3.1A)QPS A1050 (-3.2A)QPS A1050 (-4.6A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.38A | 3pocB-2x2iA:32.8 | 3pocB-2x2iA:24.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 470ARG A 642TRP A 656ASP A 659PHE A 692HIS A 740 | None | 0.40A | 3pocB-2xvgA:41.1 | 3pocB-2xvgA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 470TRP A 580TRP A 656PHE A 692HIS A 740 | None | 0.97A | 3pocB-2xvgA:41.1 | 3pocB-2xvgA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | TRP A 471ASP A 470TRP A 511ASP A 659PHE A 692HIS A 740 | EDO A1997 ( 4.5A)NoneNoneNoneNoneNone | 0.96A | 3pocB-2xvgA:41.1 | 3pocB-2xvgA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 327ILE A 328ILE A 364TRP A 406MET A 444ARG A 526TRP A 539ASP A 542PHE A 575HIS A 600 | 3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)None3CU A1001 ( 3.9A)3CU A1001 ( 3.5A)3CU A1001 (-4.6A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.49A | 3pocB-3cttA:42.1 | 3pocB-3cttA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | ASP A 327ILE A 328ILE A 364TRP A 406TRP A 441PHE A 575HIS A 600 | 3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)None3CU A1001 (-4.9A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.97A | 3pocB-3cttA:42.1 | 3pocB-3cttA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | ASP A 327ILE A 364MET A 444ARG A 526ASP A 542PHE A 575HIS A 600 | 3CU A1001 (-2.7A)3CU A1001 (-4.5A)3CU A1001 ( 3.9A)3CU A1001 ( 3.5A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 1.47A | 3pocB-3cttA:42.1 | 3pocB-3cttA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | TRP A 327ASP A 355ILE A 356ILE A 392TRP A 435MET A 473ARG A 555TRP A 568ASP A 571PHE A 604HIS A 629 | TRS A6001 ( 3.8A)TRS A6001 (-2.9A)TRS A6001 ( 4.0A)NoneTRS A6001 ( 4.6A)TRS A6001 ( 3.7A)TRS A6001 ( 4.6A)NoneTRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.38A | 3pocB-3lppA:38.0 | 3pocB-3lppA:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 8 | TRP A 327ASP A 355ILE A 356ILE A 392TRP A 435TRP A 470PHE A 604HIS A 629 | TRS A6001 ( 3.8A)TRS A6001 (-2.9A)TRS A6001 ( 4.0A)NoneTRS A6001 ( 4.6A)NoneTRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.89A | 3pocB-3lppA:38.0 | 3pocB-3lppA:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p8t | ASNS-LIKEASPARAGINYL-TRNASYNTHETASE RELATEDPROTEIN (Pyrococcusabyssi) |
PF00152(tRNA-synt_2) | 5 | ASP A 173ILE A 208ILE A 186ARG A 191ASP A 52 | None | 1.29A | 3pocB-3p8tA:undetectable | 3pocB-3p8tA:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A1279ILE A1280ILE A1315TRP A1355MET A1421ARG A1510TRP A1523ASP A1526PHE A1559HIS A1584 | ACR A 1 (-3.2A)ACR A 1 (-4.1A)NoneACR A 1 (-4.4A)ACR A 1 (-3.5A)ACR A 1 (-2.9A)ACR A 1 (-4.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.42A | 3pocB-3topA:38.7 | 3pocB-3topA:24.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | ASP A1279ILE A1280ILE A1315TRP A1355TRP A1418PHE A1559HIS A1584 | ACR A 1 (-3.2A)ACR A 1 (-4.1A)NoneACR A 1 (-4.4A)NoneACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.99A | 3pocB-3topA:38.7 | 3pocB-3topA:24.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 6 | ASP A 357ILE A 396MET A 470ARG A 552ASP A 568PHE A 601 | ACR A1001 (-3.0A)ACR A1001 (-4.9A)ACR A1001 (-3.3A)ACR A1001 (-3.0A)ACR A1001 (-2.7A)ACR A1001 (-4.3A) | 1.49A | 3pocB-3welA:40.3 | 3pocB-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 11 | TRP A 329ASP A 357ILE A 358ILE A 396TRP A 432MET A 470ARG A 552TRP A 565ASP A 568PHE A 601HIS A 626 | ACR A1001 (-4.1A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 (-4.9A)ACR A1001 ( 4.6A)ACR A1001 (-3.3A)ACR A1001 (-3.0A)ACR A1001 (-4.8A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.38A | 3pocB-3welA:40.3 | 3pocB-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 9 | TRP A 329ASP A 357ILE A 358ILE A 396TRP A 432TRP A 467TRP A 565PHE A 601HIS A 626 | ACR A1001 (-4.1A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 (-4.9A)ACR A1001 ( 4.6A)NoneACR A1001 (-4.8A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.88A | 3pocB-3welA:40.3 | 3pocB-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 299ILE A 341ARG A 463TRP A 477ASP A 480PHE A 513HIS A 540 | None | 0.44A | 3pocB-4b9yA:38.6 | 3pocB-4b9yA:24.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 299ILE A 341ASP A 480PHE A 513HIS A 540 | None | 1.30A | 3pocB-4b9yA:38.6 | 3pocB-4b9yA:24.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 299ILE A 341TRP A 410PHE A 513HIS A 540 | None | 0.90A | 3pocB-4b9yA:38.6 | 3pocB-4b9yA:24.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5d0f | UNCHARACTERIZEDPROTEIN ([Candida]glabrata) |
PF06202(GDE_C)PF14699(hGDE_N)PF14701(hDGE_amylase)PF14702(hGDE_central) | 5 | TRP A1075ASP A1078TRP A1510TRP A1239ASP A1241 | CEX A2002 (-4.9A)NoneNoneNoneCEX A2002 (-4.5A) | 1.08A | 3pocB-5d0fA:6.0 | 3pocB-5d0fA:18.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 11 | TRP A 415ASP A 443ILE A 444ILE A 480TRP A 517MET A 557ARG A 617TRP A 630ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)TRS A1001 ( 4.1A)NoneTRS A1001 ( 4.9A)TRS A1001 (-3.5A)TRS A1001 (-4.0A)NoneTRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.44A | 3pocB-5dkxA:41.8 | 3pocB-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 9 | TRP A 415ASP A 443ILE A 444ILE A 480TRP A 517TRP A 554TRP A 630PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)TRS A1001 ( 4.1A)NoneTRS A1001 ( 4.9A)TRS A1001 (-4.9A)NoneTRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.86A | 3pocB-5dkxA:41.8 | 3pocB-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 348ARG A 507TRP A 520ASP A 523PHE A 556HIS A 588 | None | 0.35A | 3pocB-5f7cA:32.2 | 3pocB-5f7cA:23.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ARG A 516TRP A 529ASP A 532PHE A 565HIS A 591 | CA A 805 ( 4.6A)None CA A 805 ( 4.6A)NoneNone | 0.54A | 3pocB-5f7sA:36.1 | 3pocB-5f7sA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF16990(CBM_35) | 5 | ARG A 614TRP A 627ASP A 630PHE A 663HIS A 689 | GLC A1116 (-2.8A)GLC A1117 (-4.6A)GLC A1117 (-2.7A)GLC A1116 (-4.6A)GLC A1117 (-4.1A) | 0.62A | 3pocB-5f7uA:33.9 | 3pocB-5f7uA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 451ILE A 488MET A 565ARG A 624TRP A 637ASP A 640PHE A 673HIS A 698 | 5GF A1021 (-2.0A)None5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 1.25A | 3pocB-5hjrA:42.9 | 3pocB-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | TRP A 423ASP A 451ILE A 452ILE A 488TRP A 525MET A 565ARG A 624TRP A 637ASP A 640PHE A 673HIS A 698 | 5GF A1021 (-3.1A)5GF A1021 (-2.0A)5GF A1021 (-3.6A)None5GF A1021 (-3.7A)5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.49A | 3pocB-5hjrA:42.9 | 3pocB-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 9 | TRP A 423ASP A 451ILE A 452ILE A 488TRP A 525TRP A 562TRP A 637PHE A 673HIS A 698 | 5GF A1021 (-3.1A)5GF A1021 (-2.0A)5GF A1021 (-3.6A)None5GF A1021 (-3.7A)5GF A1021 (-4.6A)5GF A1021 ( 4.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.92A | 3pocB-5hjrA:42.9 | 3pocB-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 441ARG A 613TRP A 627ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)EDO A1008 (-4.6A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.33A | 3pocB-5jouA:36.4 | 3pocB-5jouA:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | TRP A 442ASP A 441TRP A 482ASP A 630PHE A 663HIS A 709 | EDO A1008 (-3.7A)EDO A1008 (-2.8A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 1.00A | 3pocB-5jouA:36.4 | 3pocB-5jouA:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | TRP A 442ASP A 441TRP A 551PHE A 663HIS A 709 | EDO A1008 (-3.7A)EDO A1008 (-2.8A)NoneEDO A1008 (-4.3A)EDO A1008 (-4.0A) | 1.20A | 3pocB-5jouA:36.4 | 3pocB-5jouA:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 6 | ASP A 404ILE A 441MET A 519ARG A 600ASP A 616PHE A 649 | ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 (-3.3A)ACR A1015 (-3.1A)ACR A1015 (-2.7A)ACR A1015 (-4.3A) | 1.49A | 3pocB-5nn8A:45.4 | 3pocB-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 10 | TRP A 376ASP A 404ILE A 441TRP A 481MET A 519ARG A 600TRP A 613ASP A 616PHE A 649HIS A 674 | ACR A1015 ( 4.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 ( 4.6A)ACR A1015 (-3.3A)ACR A1015 (-3.1A)ACR A1015 (-4.8A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.62A | 3pocB-5nn8A:45.4 | 3pocB-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 7 | TRP A 376ASP A 404ILE A 441TRP A 481TRP A 516PHE A 649HIS A 674 | ACR A1015 ( 4.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 ( 4.6A)NoneACR A1015 (-4.3A)ACR A1015 (-4.0A) | 1.03A | 3pocB-5nn8A:45.4 | 3pocB-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x3j | GLYCOSIDE HYDROLASEFAMILY 31 (Kribbellaflavida) |
no annotation | 5 | ARG A 500TRP A 513ASP A 516PHE A 549HIS A 575 | GLC A 819 ( 2.9A)GLC A 822 ( 4.6A)GLC A 822 ( 2.8A)GLC A 822 ( 4.8A)GLC A 822 ( 4.0A) | 0.57A | 3pocB-5x3jA:31.6 | 3pocB-5x3jA:8.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 5 | ARG A 474TRP A 488ASP A 491PHE A 533HIS A 565 | None | 0.47A | 3pocB-5x7sA:21.8 | 3pocB-5x7sA:20.17 |